An experimental COVID-19 vaccine from Novavax appears to offer strong protection in late-stage UK, South Africa studies
APWASHINGTON (AP) — An experimental COVID-19 vaccine from Novavax appears to offer strong protection in late-stage UK, South Africa studies. Categories: AP National News



